M
Makoto Fujii
Researcher at Shiga University of Medical Science
Publications - 21
Citations - 440
Makoto Fujii is an academic researcher from Shiga University of Medical Science. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 2, co-authored 3 publications receiving 292 citations.
Papers
More filters
Journal ArticleDOI
Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
Kenichiro Takahashi,Atsushi Nishida,Takehide Fujimoto,Makoto Fujii,Makoto Shioya,Hirotsugu Imaeda,Osamu Inatomi,Shigeki Bamba,Akira Andoh,Mitsushige Sugimoto +9 more
TL;DR: The dysbiosis of CD patients is characterized by reduced abundance of multiple butyrate-producing bacteria species, which is significantly lower in C-reactive protein-positive CD patients as compared to CRP-negative CD patients.
Journal ArticleDOI
Expression of Interleukin-26 is upregulated in inflammatory bowel disease.
Makoto Fujii,Atsushi Nishida,Hirotsugu Imaeda,Masashi Ohno,Kyohei Nishino,Shigeki Sakai,Osamu Inatomi,Shigeki Bamba,Masahiro Kawahara,Tomoharu Shimizu,Akira Andoh +10 more
TL;DR: The results suggest that IL-26 plays a role in the pathophysiology of IBD through induction of inflammatory mediators.
Journal ArticleDOI
Current status of the rapid decline in renal function due to diabetes mellitus and its associated factors: analysis using the National Database of Health Checkups in Japan
Makoto Fujii,Yuko Ohno,Asuka Ikeda,Kayo Godai,Yaya Li,Yuko Nakamura,Daisuke Yabe,Kazuyo Tsushita,Naoki Kashihara,Kei Kamide,Mai Kabayama +10 more
TL;DR: In this article , the authors assessed the association between the annual rapid decline in renal function and health checkup measures, including blood pressure, to identify health guidance targets for preventing diabetic nephropathy (DN) and diabetic kidney disease (DKD) among individuals in a medical checkup system (Tokuteikenshin) in 2018.
Journal ArticleDOI
Do prognoses of patients with second primary cancers differ from those of patients with no prior cancer? A population-based study.
Haruka Kudo,Toshitaka Morishima,Makoto Fujii,M. Nagayasu,Tomotaka Sobue,Yuko Ohno,Isao Miyashiro +6 more
TL;DR: In this paper , the authors examined and compared the prognoses of cancer survivors who developed second primary cancers using the record-linked database of the population-based Cancer Registry of Osaka Prefecture and Vital Statistics in Japan.
Journal ArticleDOI
Perioperative fluid management influences complication rates and length of hospital stay in the enhanced recovery after surgery (ERAS) protocol for patients with colorectal cancer
Hiromichi Sato,Hirofumi Ota,Koji Munakata,Yusuke Matsuura,Makoto Fujii,Noriko Wada,Daisuke Takiuchi,Naoki Hama,Ko Takachi,Masao Yukawa +9 more
TL;DR: The ERAS Protocol is safe and effective for elective colorectal cancer surgery, and compliance with the ERAS protocol contributes to shorter LOHS and fewer complications.